Delivery Order SPE2DB22D3301-SPE2DB24FY7VE
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The $1,068.42 fixed-price delivery order is for the supply of 4,564,731,173 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count bottles. The contract has a completion date of May 29, 2024 and was awarded on May 28, 2024. This award is part of a larger Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,008,244 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $11,330.40 firm fixed price delivery order has a June 27, 2024 completion date. As a subsidiary of one of the largest pharmaceutical distributors, Amerisourcebergen leverages its extensive supply chain to fulfill government contracts, with a focus on serving the Department of Defense (DoD)...
- This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The contract is for the delivery of 4565753793 Ondansetron ODT 4 mg tablets in 30-count packages, valued at $51,656.95. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of 4,565,047,457 units of the prescription medication Ondansetron ODT 4 mg tablets. The $1,251.66 firm fixed-price contract was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 2, 2024. This appears to be a delivery order under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide Ondansetron ODT 4 mg tablets to the U.S. government. The $3,125.70 Delivery Order contract has a firm fixed price and an ultimate completion date of July 5, 2024. Amerisourcebergen, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA to supply a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Delivery Order valued at $8,813.96, with a firm fixed price and an ultimate completion date of April 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of 4564389589 Ondansetron ODT 4 MG Tablet 30S. The $2,360.32 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, the medical supply chain division of the Department of Defense (DoD), and has an ultimate completion date of April 25, 2024. Amerisourcebergen, one of the largest pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,801,874 units of Ondansetron ODT 4 mg tablets. The $14,147.81 contract was awarded on June 4, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of June 5, 2024. The contract is structured as a firm fixed-price Delivery Order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4559438380 units of the medication Ondansetron ODT 4 mg tablet. The $4,413.13 firm fixed price contract was awarded on December 21, 2022 by the Defense Logistics Agency (DLA), with a completion date of December 22, 2022. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within...
- This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at up to $3,326.29, is for the delivery of 4564360914 - Ondansetron ODT 4 mg Tablets in 30-count packages. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY7VEDelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564793392 Ondansetron ODT 4 mg tablets. The contract, valued at $1,388.49, was awarded on June 3, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 4, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems, and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/3/24 |